CV

CapsoVision

Stock NASDAQ – Stock Market Prices, News & Analysis

Company developing innovative medical devices, notably endoscopic capsules for gastrointestinal diagnostics.

$ 6.45
3.20 %

CapsoVision

$ 6.45
3.20 %
CV

Company developing innovative medical devices, notably endoscopic capsules for gastrointestinal diagnostics.

Price history of CapsoVision
Price history of CapsoVision

Performance & Momentum

6 Months 38.12 %
1 Year 84.29 %
3 Years 84.29 %
5 Years 46.59 %

Strategic Analysis

CapsoVision • 2026

CapsoVision positions itself as an innovative player in the medical device sector, specializing in endoscopic capsules for gastrointestinal diagnosis. Its differentiated technology aims to improve diagnostic accuracy while providing a less invasive solution than traditional methods.

Strengths
  • Innovative medical technology with strong disruptive potential in gastroenterology
  • Focus on a niche segment with significant unmet clinical needs
  • Sustained growth in the medium term with gradual adoption in the American market
Weaknesses
  • Dependence on regulatory validation and clinical acceptance
  • Limited presence outside the United States, which could hinder international expansion
Momentum

The sustained positive momentum reflects a growing interest from investors, bolstered by consistent performance across multiple time horizons and a market dynamic favorable to medical innovations. The lack of recent news implies a waiting phase, emphasizing the importance of upcoming clinical or commercial announcements.

Similar stocks to CapsoVision

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone